Last reviewed · How we verify

NCT06752642

CD vs IOD Opposing Mandibular IOD : Bone Height Changes of the Premaxilla

Completed NA Last updated 31 December 2024
What this trial tests

NA trial testing Implant overdenture in Edentulism in 20 participants. Completed in 15 October 2024.

Timeline
10 January 2022
Primary endpoint
15 September 2023
15 October 2024

Quick facts

Lead sponsorMansoura University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date10 January 2022
Primary completion15 September 2023
Estimated completion15 October 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University

Who can join

Adults 50 to 70, any sex, with Edentulism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate bone resorption of the anterior region of maxillary arch. The main questions it aims to answer are: Does implants assisting maxillary complete denture enhance stability, retention and mastication of the patient ? Does implants assisting maxillary complete denture reduce bone resorption in the anterior region of maxilla ? Participants will: * receive 2 implants with attachments assisting their maxillary complete denture * Visit the clinic once every 6 months for checkups and tests

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Edentulism

Currently open trials in the same condition.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06752642.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing